General Information of Drug (ID: DMQTDD1)

Drug Name
DYV700
Indication
Disease Entry ICD 11 Status REF
Gout FA25 Phase 2 [1]
Cross-matching ID
TTD ID
DB5U4E

References

1 ClinicalTrials.gov (NCT04130204) Randomized, Double-blinded, Placebo-controlled Study of the Efficacy and Safety of DYV700 for Reducing Pain Associated With an Acute Gout Flare. U.S.National Institutes of Health.